![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
SAFETY AND PK OF SUBCUTANEOUS GS-6207, A NOVEL HIV-1 CAPSID
INHIBITOR
|
|
|
Reported by Jules Levin
CRI 2019 March 4-7 Seattle
Jennifer E Sager, Rebecca Begley, Martin Rhee, Steve K. West, John Ling,
Scott D. Schroeder, Winston C. Tse, Anita Mathias
Gilead Sciences, Inc, Foster City, CA, USA
![0308191](../images/030819/030819-7/0308191.gif)
![0308192](../images/030819/030819-7/0308192.gif)
![0308193](../images/030819/030819-7/0308193.gif)
![0308194](../images/030819/030819-7/0308194.gif)
![0308195](../images/030819/030819-7/0308195.gif)
![0308196](../images/030819/030819-7/0308196.gif)
![0308197](../images/030819/030819-7/0308197.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|